BD Announces Results for 2011 Second Fisc... (onth period ended March 31 2011 BD Medic...)

BD Announces Results for 2011 Second Fiscal Quarter

Date:4/26/2011

onth period ended March 31, 2011, BD Medical revenues increased 0.8 percent, or 0.1 percent on a foreign currency-neutral basis.

In the BD Diagnostics segment, worldwide revenues for the quarter were $605 million, representing an increase of 8.9 percent compared with the prior-year period, or 6.5 percent on a foreign currency-neutral basis. Revenues reflected solid growth in Preanalytical Systems safety-engineered products and strong growth in Diagnostic Systems infectious disease platforms. For the six-month period ended March 31, 2011, BD Diagnostics revenues increased 4.9 percent, or 3.6 percent on a foreign currency-neutral basis.

In the BD Biosciences segment, worldwide revenues for the quarter were $335 million, representing an increase of 4.1 percent compared with the prior-year period, or 0.4 percent on a foreign currency-neutral basis. Segment revenue growth was negatively impacted by about 12 percentage points due to certain factors. About 8 percentage points of the impact was due to an unfavorable comparison resulting from strong sales related to supplemental spending in Japan and stimulus spending in the U.S. in fiscal year 2010, and about 3 percentage points resulted from the effects of the earthquake and tsunami in Japan. Segment growth was driven primarily by instrument and reagent sales in the Cell Analysis unit. Discovery Labware revenues in the U.S. were negatively impacted by weakness in core consumables due to lower pharmaceutical spending and academic sector sales. For the six-month period ended March 31, 2011, BD Biosciences revenues increased by 3.9 percent, or 1.9 percent on a foreign currency-neutral basis.

Geographic ResultsSecond quarter revenues in the U.S. were $829 million, representing an increase of 4.7 percent compared with the prior-year period. Revenues outside of the U.S. were $1.093 billion, representing an increase of 8.5 percent compared with the prior-year period, or 4.6 percent on a forei
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine technology :

1. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
2. Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Dose Adjustment of Paclitaxel in Non-Small Cell Lung Cancer
3. Novavax Announces Senior Management Appointments
4. Roper Industries Announces Record First Quarter Results
5. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
6. Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events
7. HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
8. Express Scripts Announces Intention to Commence a Debt Offering
9. ConvaTec Healthcare Announces 2010 Year-End Earnings Call
10. Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System
11. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options. ...

(Date:5/22/2013)... 22, 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) ... about some recent company developments. As Medifirst continues to ... communication with shareholders. Integrating social media into its investor ... and will post updates on Twitter. The Facebook homepage ... Says CEO Bruce J. ...

(Date:5/22/2013)... TORONTO , May 22, 2013 Generex ... three presentations demonstrating the superiority of the AE37 breast ... Express, Inc. ( www.antigenexpress.com ). The presentations will be ... of Clinical Oncology (ASCO) to be held in ... 4, 2013. The presentation entitled " Booster ...

Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Medifirst Solutions, Inc. Announces Update To Shareholders 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4

[0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Medifirst Solutions, Inc. Announces Update To Shareholders [0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine

... N. J. ,Oct. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical ... developer, manufacturer and marketer of medical devices worldwide, today ... hand-held M series ultrasound platforms at the American Society ... October 14-18, 2011. The M7 ...

... MAHWAH, N.J., Oct. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray ... a leading developer, manufacturer and marketer of medical ... A3 anesthesia system, an expansion of its A ... that complements Mindray,s broad range of ultrasound and ...

Cached Medicine Technology:Mindray Introduces Enhancements for M Series Ultrasound Platforms at ASA 2 Mindray Announces Expansion of its A Series Anesthesia Portfolio 2

Mindray Introduces Enhancements for M Series Ultrasound Platforms at ASA Mindray Announces Expansion of its A Series Anesthesia Portfolio

(Date:5/22/2013)... A new study shows there is a gender ... American young children one that does not appear ... United States, girls had higher levels of self-regulation than ... their behavior and impulses, follow directions, and persist on ... and college completion, in past studies by Oregon State ...

(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...

(Date:5/22/2013)... News) -- Over the next two decades, the cost ... to more than double, topping more than $180 billion ... factor driving the increase: an aging population. The report, ... Stroke Association, was published May 22 in the journal ... health care system," Dr. Bruce Ovbiagele, chairman of the ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Phelps Memorial ... the Westchester Lung Nodule Center for individuals who ... lung cancer care. Lung cancer is the deadliest form of ... people in the U.S. die from lung cancer than from ... all cancers, early detection increases survival rates. It is ...

[0] 'Boys will be boys' in US, but not in Asia [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care

... PLAINS, N.Y. , Jan. 14 APS Healthcare ... first two winners of its Outcomes Informed Care (OIC) Award, Pepper ... Mona Saylor , MSW, LISW, of Columbia, S.C. ... contribution to the APS OIC initiative, designed to increase the effectiveness ...

... But tumor-type mixups don,t necessarily negate findings, experts say ... rely on specific tumor cell lines when developing new ... to be, a Dutch team reports. , Their study ... lines widely used for worldwide research were actually cell ...

... , UPLAND, Calif. , ... has launched its first line of all natural food bars ... net profits after taxes are donated to Marathon of Miracles, ... www.marathonofmiracles.org . , MOM all natural bars come in two ...

... , Medifast revenue has had over 40% compound year -over-year ... MILLS, Md. , Jan. 14 Medifast, Inc. (NYSE: ... attacks on its stock in a case of outright, deliberate, and possibly ... Minkow , a convicted felon, and his Fraud Discovery Institute (FDI) posted ...

... ... Bedroom , ... NY (Vocus) January 14, 2010 -- Austin Air Systems, America’s leading indoor air ... (NSF) to launch a new National Sleep Foundation-branded air purification system specifically designed ...

... ... the H1N1 shot , ... MA (Vocus) January 14, 2010 -- With flu experts predicting another wave of H1N1 flu, ... vaccination is now readily available and covered by your BCBSMA health plan. BCBSMA members are ...

Cached Medicine News:Health News:APS Healthcare Issues First Award to South Carolina Providers Using Data to Increase Effectiveness of Mental Health Treatment 2 Health News:APS Healthcare Issues First Award to South Carolina Providers Using Data to Increase Effectiveness of Mental Health Treatment 3 Health News:Incorrect Cell Lines Used for Worldwide Cancer Research 2 Health News:Incorrect Cell Lines Used for Worldwide Cancer Research 3 Health News:Marathon of Miracles(TM) All Natural Food Bars and Nuts Begin the Race Towards Good Health 2 Health News:Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner 2 Health News:Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner 3 Health News:Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner 4 Health News:Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner 5 Health News:Austin Air Systems Partners With National Sleep Foundation 2 Health News:Austin Air Systems Partners With National Sleep Foundation 3 Health News:Austin Air Systems Partners With National Sleep Foundation 4 Health News:Blue Cross Blue Shield of Massachusetts Urges Members to Get Their Flu Shot 2

APS Healthcare Issues First Award to South Carolina Providers Using Data to Increase Effectiveness of Mental Health Treatment Incorrect Cell Lines Used for Worldwide Cancer Research Marathon of Miracles(TM) All Natural Food Bars and Nuts Begin the Race Towards Good Health Medifast, Inc. Complaints Against FDI Pending With the United States Department of Justice, the United States Securities and Exchange Commission, the Maryland Securities Commissioner Austin Air Systems Partners With National Sleep Foundation Blue Cross Blue Shield of Massachusetts Urges Members to Get Their Flu Shot

... for laboratories looking for time and cost ... operation in terms of easy reagent cassette ... on-board stability., ,URISYS 2400 is a ... capability for medium to high volume laboratories ...

... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...

Acufex arthroscopic electrodes are insulated for use in all fluids and come in boxes of 10....

... The Assistant Free ... retractors utilizing Velcro® straps. ... of the surgeon's operative ... personnel. Three retractor styles ...

Medicine Products:

URISYS 2400 Small Joint Ball Electrode Electrode Assistant Free™ Knee Retractor System